Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer

20 Jan 2009

Abstract excerpt

The aim of this study was to identify deregulated transcription factors (TFs) in colorectal cancer (CRC) and to evaluate their relation with the recurrence of stage II CRC and overall survival. Microarray-based transcript profiles of 20 normal mucosas and 424 CRC samples were used to identify 51 TFs displaying differential transcript levels between normal mucosa and CRC. For a subset of these we provide in vitro...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Chromatin Remodeling and Cancer
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19156145
DOI: 10.1038/sj.bjc.6604884

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancerPMID 19156145Read ↗

A SMAD4 ‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancerSemantic proximity Read ↗

A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancerSemantic proximity Read ↗

Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.Semantic proximity Read ↗

Evaluation of the Prognostic Value of Four ECM-Associated Genes in Recurrence and Metastasis of Colorectal CancerSemantic proximity Read ↗

An oncoembryology approach uncovers SoxC-driven regulation of colon development and cancerSemantic proximity Read ↗

Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancerSemantic proximity Read ↗

SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer.Semantic proximity Read ↗

Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancerSemantic proximity Read ↗

SOX9 expression predicts relapse of stage II colon cancer patientsSemantic proximity Read ↗

Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence.Semantic proximity Read ↗

Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic AnalysisSemantic proximity Read ↗

PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.